Abbott Quarterly Earnings Beat Estimates on Device SalesBy
All four business units reported revenue gains for period
CEO White wants more Alere data; ‘fair amount’ not provided
Abbott Laboratories, embroiled in a contentious acquisition of the medical testing company Alere Inc., said second-quarter profit topped analysts’ estimates as device demand led rising sales across all four of its business segments.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.